drugset / Trial / NCT05626023
A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease
Phase 1/2
Completed
9 enrolled
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Changhai Hospital · collab
NaSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of human TH-SC01 cell injection for the treatment of perianal fistulas in Crohn's Disease
Timeline
- Start
- 2022-01-30
- Primary completion
- 2023-08-30
- Completion
- 2025-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TH-SC01 | Cell therapy | 6e+06 cells/kg | — |
| Subject | TH-SC01 | Cell therapy | 1.2e+08 cells/kg | — |
| Subject | TH-SC01 | Cell therapy | 1.8e+08 cells/kg | — |